0HIY.LAtara Biotherapeutics Inc

À propos

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

www.atarabio.com

Statistiques clés

Capitalisation

102.37M

BPA

2.61

Rendement dividende

0.00%

Bêta

0.11

P/B

-5.86

ROE

-84.9%

Secteur

Healthcare

Industrie

Medical - Pharmaceuticals

PDG

Anhco Nguyen

Employés

14

Date IPO

2018-01-29

Pays

US